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Abstract
Objectives This study aimed to analyse depression and anxiety symptoms changes from the first to the third trimester of
pregnancy in non-smokers versus quitters versus continuous smokers, and the contribution of depression and anxiety
symptoms to continued tobacco consumption during pregnancy.
Methods The sample comprises 850 Spanish pregnant women (595 non-smokers, 123 quitters, and 132 continuous
smokers), assessed at the first and the third trimester of pregnancy with a questionnaire concerning socio-demographic,
obstetric, and tobacco consumption information, and measures of depression and anxiety.
Results Continuous smokers during pregnancy showed more depression and anxiety symptoms than both non-smokers and
quitters and no changes from the first trimester to the third trimester of pregnancy, while both non-smokers and quitters
revealed a decrease in depression and anxiety symptoms. More anxiety symptoms at the first trimester (OR 1.03) and
depression symptoms at the third trimester (OR 1.14) were associated with continued smoking during pregnancy.
Conclusions Anxiety and depression symptoms need to be considered to screening for women at risk of smoking during
pregnancy. Future prenatal smoking cessation interventions must take into account these variables.
Keywords Pregnancy  Tobacco consumption  Continuous smokers  Depression  Anxiety
Introduction
Tobacco consumption during pregnancy is one of the main
factors associated with adverse health outcomes for women
and their children (USDHHS 2014). Although some
women spontaneously quit smoking after knowing that
they are pregnant (Schneider et al. 2010), other pregnant
women continue smoking even knowing the risk involved.
Previous studies on tobacco consumption during preg-
nancy have compared smokers with quitters characteristics
(e.g. Coleman-Cowger et al. 2013; Erlingdottir et al. 2014;
Goedhart et al. 2009) or smokers with non-smokers (Al-
Sahab et al. 2010; Giglia et al. 2007; Orr et al. 2012).
Including women who have never smoked and those who
quit smoking during pregnancy in the same non-smokers
group (e.g. Al-Sahab et al. 2010; Orr et al. 2012) may
provide underrepresented data as different consumption
profiles and associated factors are considered as the same
one. However, knowing about the differences between
smokers and quitters may provide relevant information,
namely regarding why some smokers quit and others
continue smoking during pregnancy. On the other hand,
exploring the differences among the three groups—non-
smokers, quitters, and continuous smokers across preg-
nancy—may also add relevant information to the field of
tobacco consumption, mainly regarding the benefits of
quitting smoking during pregnancy.
More information on the main aspects associated with
continuing smoking throughout pregnancy is needed to
target relevant causes and to offer the necessary specific
support to quit smoking during pregnancy. Research on this
subject lacks a longitudinal and prospective approach with
biochemical test of smoking abstinence, as data may be
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biased by women’s memory and/or by social desirability
due to social pressure on quitting smoking (Mı´guez and
Pereira 2018). Studies have been based mostly on non-
confirmed information of abstinence from retrospective
self-reports (e.g. Dupraz et al. 2013) or cross-sectional
surveys focusing on abstinence in one specific moment of
pregnancy (Erlingdottir et al. 2014; Giglia et al. 2007;
Goedhart et al. 2009). Cross-sectional studies show partial
results because they do not assess changes in major vari-
ables that could differently affect consumption depending
on the period of gestation evaluated. Therefore, it is nec-
essary to use a robust methodology that allows the obten-
tion of more precise data.
Smoking during pregnancy has been associated with
several socio-demographic risk factors, such as a young
age and low educational level (Balwicki et al. 2016; Krstev
et al. 2012; Orton et al. 2014), low economic level (Bal-
wicki et al. 2016; Krstev et al. 2012; Maxson et al. 2012),
unemployment (Balwicki et al. 2016; Orton et al. 2014;
Smedberg et al. 2014), unexpected pregnancy (Suzuki et al.
2010), and having a smoking partner (Orr et al. 2012). On
the other hand, women intending to breastfeed were found
to be less likely to smoke during pregnancy (Haslam et al.
2003). Smoking during pregnancy has also been associated
with depression and/or anxiety symptoms, but results are
somewhat controversial. The majority (Linares-Scott et al.
2009; Maxson et al. 2012; Smedberg et al. 2014; Tong
et al. 2016), but not all (Beijers et al. 2014; Blaga et al.
2017; Meghea et al. 2010), studies have linked smoking
with the presence of depression or depression symptoms.
Moreover, although the relationship between anxiety and
smoking in pregnancy has been less investigated, some
studies suggest that smoking during pregnancy is more
prevalent in women with higher levels of anxiety (Blaga
et al. 2017; Goedhart et al. 2009; Tong et al. 2016), while
others have not found this association (e.g. Beijers et al.
2014; Massey and Compton 2013).
Pregnancy is a stage of critical psychological vulnera-
bility for women. Tobacco consumption and psychological
adjustment problems during pregnancy are strongly asso-
ciated and have a similar adverse impact on the infant
health and development. For example, maternal depression
during pregnancy was found to increase the risk of pre-
maturity, low birthweight, and later emotional and beha-
vioural problems (see Field 2011). Depression and anxiety
symptoms were associated with tobacco consumption, and
tobacco consumption was found to affect depression and
anxiety symptoms (Taylor et al. 2014). However, the
interaction between these two aspects need to be better
explored, mainly at different times of pregnancy, because it
is unclear whether these depressive and anxious symptoms
are influenced by tobacco consumption depending on the
trimester of pregnancy. Many smokers think that smoking
offers mental health benefits; however, some studies show
the opposite, that is, an association between smoking ces-
sation and a decrease in depression, anxiety, and stress, as
well as an improvement in mood and quality of life (Taylor
et al. 2014). To explore the influence of continuing or
quitting smoking during pregnancy on women’s depression
and anxiety symptoms over pregnancy is relevant for
clinical practice and research.
This study aimed to analyse: (1) anxiety and depression
symptoms changes from the first to the third trimester of
pregnancy in non-smokers versus quitters versus continu-
ous smokers and (2) the contribution of anxiety and
depression symptoms to continued tobacco consumption in
women from the first to the third trimester of pregnancy.
Methods
Participants
A total of 915 pregnant women were invited to participate
in the study, 11 declined to participate and three could not
be enrolled, as they were not proficient in Spanish. From
the 901 women who accepted to participate and were
assessed at the first trimester, 28 had suffered a miscar-
riage, 14 could not be contacted, and two declined to
participate at the third trimester of pregnancy. From 857
(95.1%) women assessed at the third trimester of preg-
nancy, seven reported having quit smoking after the first
trimester of pregnancy and were excluded from the anal-
yses. Therefore, the sample of this study was comprised of
850 pregnant women assessed at the first (M = 9.93 ges-
tational weeks; SD = 4.19; age range 4–20 weeks) and
third (M = 33.28 gestational weeks; SD = 2.04; age range
26–40) trimester of pregnancy. Participants’ age ranged
between 18 and 46 years old (M = 32.72 years; SD =
4.35). Most participants were married or cohabiting
(83.3%). More than half were over 30 years old (72.0%),
were employed at the first trimester of pregnancy (71.2%),
were primiparous (66.4%), had university studies (53.1%),
and had a maximum household income of 2000 euros net
per month (57.4%).
More than half of pregnant women had never smoked or
had given up smoking before pregnancy (70.0%; n = 595),
while 14.5% (n = 123) spontaneously quitted at the first
pregnancy trimester and 15.5% (n = 132) continued
smoking during pregnancy.
Procedure
The present research was conducted in accordance with the
Declaration of Helsinki and received previous approval
from the ethical commission of all institutions involved.
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Pregnant women attending a primary health public care
service in Northwest Spain (December 2012–September
2014) were recruited through consecutive probabilistic
sampling at the first trimester of pregnancy. The number of
births in the year preceding the study according to official
data was used to calculate the sample size and to insure
representativeness with a confidence level of 95% and an
accuracy of 3.4%. The aims and procedures were
explained, and pregnant women who were willing to par-
ticipate provided a written informed consent. Following,
two trained psychologists carried out the interviews
individually.
This is a observational prospective longitudinal study
with two assessment waves, at the first and the third tri-
mester of pregnancy. Women were assessed at both
assessment waves with an ad hoc questionnaire on socio-
demographic, obstetric, and tobacco consumption infor-
mation, and measures of depression and anxiety symptoms.
The average time for assessment of each participant in each
trimester was 20 min. At the third trimester, an appoint-
ment was performed by telephone to schedule the inter-
view. Pregnant women choose the day, time, and place of
the interview. Most women (80.0%) preferred to perform
this assessment in their homes.
To avoid potential biases in the classification of women
in their consumption group, biochemical tests (cotinine
concentration in urine at the first trimester of pregnancy
and carbon monoxide in expired air at the third trimester of
pregnancy) were performed to confirm the self-reported
consumption status. Likewise, in regression analysis, the
socio-demographic and obstetric variables that differenti-
ated the consumption groups (confounding variables) were
controlled.
Pregnant women were classified into three groups based
on their self-report tobacco consumption and the results of
the biochemical test: (1) non-smokers—non-smoking
before (or since long time before) pregnancy and
throughout pregnancy; (2) quitters—quitting smoking at
the first trimester of pregnancy (when pregnancy sus-
pected/confirmed) and non-smoking throughout pregnancy;
(3) continuous smokers—maintained tobacco consumption
throughout pregnancy.
Measures
Socio-demographic and tobacco consumption information
Information regarding socio-demographic characteristics
(e.g. age, marital and occupational status, parity, education,
and monthly household income), psychopathology diag-
nosed, pregnancy-related variables (e.g. number of gesta-
tional weeks, planned pregnancy, and breastfeeding
intention) and consumption information (e.g. smoking
status and having a partner who smokes) was obtained for
this study.
Self-reports of smoking abstinence were biochemically
verified through urinary cotinine by Cotinine Test Medi-
marketing (cut-off 200 ng/mL) at the first trimester and
through the evaluation of expired air carbon monoxide
(CO) at the third trimester (cut-off of 5 ppm) using a car-
bon monoxide monitor (Model Smokerlyzer Pico Simple;
Bedfont Technical Instruments Ltd., Sittingbourne, Kent,
UK). Biochemical measurement and self-report were
combined to establish smoking status.
Edinburgh Postnatal Depression Scale (EPDS; Cox et al.
1987)
EPDS is a 10-item self-reported questionnaire designed to
assess the intensity of depression symptoms within the
previous 7 days. Higher scores indicate more intensity of
depression symptoms. It is the most widely used ques-
tionnaire for detection of postpartum depressive symptoms,
although it has also been validated to detect depression
during pregnancy. In the Spanish validation (Va´zquez and
Mı´guez 2019), the recommended cut-off score is 10. In the
present study, the EPDS showed good internal consistency
(Cronbach’s a = 0.85 at the first trimester of pregnancy and
0.77 at the third trimester of pregnancy).
State Anxiety Scale of State-Trait Anxiety Inventory (STAI;
Spielberger et al. 1970; Spanish version TEA, 1982)
The STAI-S consists of 20-item self-reported scale
designed to assess the current state of anxiety. Higher
scores indicate higher anxiety symptoms. The STAI-S
Spanish version proposed a clinical cut-off of 32 (75th
percentile) to screen for high anxiety in women. In the
present study, the STAI-S showed excellent internal con-
sistency (Cronbach’s a = 0.94 at the first trimester of
pregnancy and 0.91 at the third trimester).
Data analysis
Preliminary analyses were performed using Chi-square
tests to analyse the characteristics (socio-demographic,
obstetric, and psychological) of smoking status groups
(non-smokers, quitters, continuous smokers). A repeated-
measures multivariate analysis of variance (MANOVA)
was performed to analyse anxiety and depression symp-
toms changes from the first to the third trimester of preg-
nancy in non-smokers versus quitters versus continuous
smokers. The model included smoking status groups as the
between-subjects factor and women’s depression and
anxiety symptoms as within-subjects’ factors with two
levels: EPDS and STAI-S scores at the first and the third
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trimester of pregnancy. A MANOVA was performed to
explore differences between the smoking status groups on
women’s depression and anxiety symptoms at the first and
the third trimester of pregnancy. The model included
smoking status groups as the independent variable and
women’s depression and anxiety symptoms (at the first and
the third trimester of pregnancy) as dependent variables.
Pairwise comparisons were applied to assess within and
between group differences.
A three-step logistic regression was performed to anal-
yse anxiety and depression symptoms associated with
continued tobacco consumption in women from the first to
the third trimester of pregnancy. The first step (enter
method) was performed to control confounding variables
associated with the smoking status groups (specifically,
marital status, education, monthly household income, par-
ity, smoking partner, pregnancy influenced work, planned
pregnancy, breastfeeding intention, and previous psy-
chopathology diagnosed). The second and third steps were
made to know which psychological variables predicted
consumption status, specifically anxiety and depression
symptoms at the first and third trimester of pregnancy. The
second step (stepwise method) was performed to clarify
whether the strongest predictor of continued tobacco con-
sumption in women during pregnancy is anxiety or
depression symptoms at the first trimester of pregnancy.
The third step (stepwise method) was performed to clarify
whether there are anxiety or depression symptoms at the
third trimester of pregnancy that are associated with con-
tinued tobacco consumption in women during pregnancy
(adjusting the model for anxiety and depression symptoms
at the first trimester of pregnancy). All the three steps
included continued tobacco consumption during pregnancy
as dependent variable.
Cramer’s V coefficients and partial eta-squared (gp2)
were calculated to estimate the effect size. Data were
analysed with IBM SPSS 23.0 version (SPSS Inc,
Chicago).
Results
Preliminary analyses: associations
between smoking status and socio-demographic,
obstetric, and psychological variables
Significant associations were found between smoking
status and socio-demographic, obstetric, and psychological
characteristics (see Table 1). Regarding socio-demo-
graphic characteristics, non-smokers are more likely to be
married or living with partner than continuous smokers
during pregnancy, to be higher educated, less likely to
receive a monthly salary lower than 2000€, more likely to
live with a non-smoking partner than quitters or continu-
ous smokers, and less likely to be multiparous than quit-
ters. Quitters are more likely to be higher educated and
less likely to live with a non-smoking partner than con-
tinuous smokers during pregnancy. Regarding obstetric
characteristics, non-smokers are more likely to report that
pregnancy did not influence their work than quitters or
continuous smokers during pregnancy, and more likely to
report that pregnancy was desired and that they intended
to breastfeed their infant than continuous smokers.
Regarding psychological characteristics, non-smokers are
less likely to present previous psychopathology than
continuous smokers, less likely to be depressed or anxious
at the first trimester of pregnancy than quitters or con-
tinuous smokers, and less likely to be depressed or anx-
ious at the third trimester of pregnancy than continuous
smokers during pregnancy.
Differences on women’s depression and anxiety
from the first to the third trimester of pregnancy,
according to smoking status
The repeated-measures MANOVA revealed significant
multivariate (Wilk’s Lambda = 0.98, F2,846 = 6.87,
p = 0.001, gp2 = 0.02) and univariate time effects on
women’s depression and anxiety symptoms. Women’s
depression and anxiety symptoms decreased from the first
to the third trimester of pregnancy. No significant effects of
the interaction between time and smoking status were
found on women’s depression and anxiety. However,
pairwise comparisons noted that non-smokers and quitters
revealed a significant decrease on depression and anxiety
symptoms, while continuous smokers during pregnancy
revealed no significant changes on depression and anxiety
symptoms from the first to the third trimester of pregnancy
(see Table 2 and Fig. 1A, B).
The MANOVA results were statistically significant. The
univariate results revealed significant effects of smoking
status on women’s depression (F2,847 = 14.98, p\ 0.001,
gp2 = 0.03) and anxiety symptoms (F2,847 = 14.49,
p\ 0.001, gp2 = 0.03) at the first trimester of pregnancy
and on women’s depression (F2,847 = 16.88, p\ 0.001,
gp2 = 0.04) and anxiety symptoms (F2,847 = 14.56,
p\ 0.001, gp2 = 0.03) at the third trimester of pregnancy.
Pairwise comparisons revealed that continuous smokers
during pregnancy showed more depression and anxiety
symptoms at the first and at the third trimester of pregnancy
than non-smokers and quitters. No differences were found
between non-smokers and quitters on depression and anx-
iety symptoms at the first and the third trimester of
pregnancy.
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Table 1 Associations between continued smoking status and socio-demographic, obstetric, and psychological variables among Spanish pregnant
women in 2014
(1)
Non-smokers
(n= 595)
(2)
Quitters
(n= 123)
(3)
Smokers
(n = 132)
v2 V Group comparisons
% (n) % (n) % (n)
Socio-demographic variables
Age (years)
[ 30 73.3 (436) 69.1 (85) 68.9 (91) 1.60 1 = 2 = 3
B 30 26.7 (159) 30.9 (38) 31.1 (41) 1 = 2 = 3
Marital status
Married/cohabiting 85.5 (509) 81.3 (100) 75.0 (99) 9.05** 0.10 1 = 2; 1[ 3*; 2 = 3
Single/divorced 14.5 (86) 18.7 (23) 25.0 (33) 1 = 2 = 3
Higher education
Yes 60.5 (360) 48.0 (59) 24.2 (32) 58.53*** 0.26 1[ 2[ 3***
No 39.5 (235) 52.0 (64) 75.8 (100) 1\ 2\ 3***
Occupational status
Employed 72.9 (434) 70.7 (87) 63.6 (84) 4.57 1 = 2 = 3
Unemployed 27.1 (161) 29.3 (36) 36.4 (48) 1 = 2 = 3
Monthly salary
[ 2000 40.1 (222) 27.8 (30) 26.4 (28) 11.25** 0.12 1 = 2 = 3
B 2000 59.9 (332) 72.2 (78) 73.6 (78) 1\ 2, 3*
Parity
Primiparous 63.0 (375) 79.7 (98) 68.9 (91) 13.12** 0.12 1\ 2**; 1, 2 = 3
Multiparous 37.0 (220) 20.3 (25) 31.1 (41) 1 = 2 = 3
Smoking partner
Yes 21.3 (127) 48.0 (59) 65.9 (87) 114.18*** 0.37 1\ 2\ 3***
No 78.7 (468) 52.0 (64) 34.1 (45) 1[ 2[ 3***
Obstetric variables
Pregnancy-influenced work
Yes 10.4 (62) 18.7 (23) 17.4 (23) 9.44** 0.11 1 = 2 = 3
No 89.6 (533) 81.3 (100) 82.6 (109) 1[ 2, 3*
Pregnancy desired
Yes 89.7 (534) 84.5 (104) 81.8 (108) 7.71* 0.10 1 = 2; 1[ 3*; 2 = 3
No 10.3 (61) 15.4 (19) 18.2 (24) 1 = 2 = 3
Breastfeeding intention
Yes 89.4 (532) 87.0 (107) 81.1 (107) 7.10* 0.09 1 = 2; 1[ 3*; 2 = 3
No 10.6 (63) 13.0 (16) 18.9 (25) 1 = 2 = 3
Psychological variables
Psychopathology
Yes 11.4 (68) 13.8 (17) 20.5 (27) 7.75* 0.10 1 = 2; 1\ 3*; 2 = 3
No 88.6 (527) 86.2 (106) 79.5 (105) 1 = 2; 1[ 3*; 2 = 3
Depression at first trimester
of pregnancy
EPDS C 10 12.4 (74) 22.8 (28) 30.3 (40) 28.58*** 0.18 1\ 2, 3***
EPDS\ 10 87.6 (521) 77.2 (95) 69.7 (92) 1[ 2, 3***
Anxiety at first trimester
of pregnancy
STAI-S C 32 5.2 (31) 9.8 (12) 16.7 (22) 20.98*** 0.16 1\ 2, 3***
STAI-S\ 32 94.8 (564) 90.2 (111) 83.3 (110) 1[ 2, 3***
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Depression and anxiety symptoms associated
with continued tobacco consumption in women
from the first to the third trimester of pregnancy
The first step regression was statistically significant
(v7
2 = 23.32, p = 0.006). The model explained 10–14% of
the variance in continued tobacco consumption (Cox and
Snell R2 = 0.10, Nagelkerke R2 = 0.14) and correctly
classified 66.4% of cases. Women without a college degree
(OR = 2.46) and with smoker partner (OR = 2.27) were
more likely to continue smoking during pregnancy.
Table 1 (continued)
(1)
Non-smokers
(n= 595)
(2)
Quitters
(n= 123)
(3)
Smokers
(n = 132)
v2 V Group comparisons
% (n) % (n) % (n)
Depression at third trimester
of pregnancy
EPDS C 10 8.9 (53) 12.2 (15) 16.7 (22) 7.26* 0.09 1 = 2; 1\ 3*; 2 = 3
EPDS\ 10 91.1 (542) 87.8 (108) 83.3 (110) 1 = 2; 1[ 3*; 2 = 3
Anxiety at third trimester
of pregnancy
STAI-S C 32 3.7 (22) 7.3 (9) 9.1 (12) 8.07* 0.10 1 = 2; 1\ 3*; 2 = 3
STAI-S\ 32 96.3 (573) 92.7 (114) 90.9 (120) 1 = 2; 1[ 3*; 2 = 3
Data collection: Spain, 2013–2014
V Cramer’s V, EPDS Edinburgh Postnatal Depression Scale, STAI-S State Anxiety Scale of State-Trait Anxiety Inventory
*p\ 0.05; **p\ 0.01; ***p\ 0.001
Table 2 Between and within
differences on Spanish women’s
depression and anxiety
symptoms from the first to the
third trimester of pregnancy,
according to continued smoking
status in 2014
Symptoms (1)
Non-smokers
(n = 595)
(2)
Quitters
(n = 123)
(3)
Smokers
(n = 132)
F df
M SD M SD M SD
Depression
First trimester (a) 4.72 4.11 5.60 4.82 6.99 5.22 14.98*** 2, 847 1, 2\ 3I
Third trimester (b) 4.21 3.52 4.59 3.87 6.20 3.48 16.88*** 2, 847 1, 2\ 3II
a[ b1 a[ b2 a = b3
Anxiety
First trimester (a) 14.00 9.45 15.90 11.30 19.27 12.81 14.49*** 2, 847 1, 2\ 3III
Third trimester (b) 12.57 8.54 13.54 8.73 17.16 10.15 14.56*** 2, 847 1, 2\ 3IV
a[ b1 a[ b2 a = b3
Data collection: Spain, 2013–2014
M Mean, SD Standard Deviation, multivariate effects of repeated-measures MANOVA, Wilk’s
Lambda = 0.98, F2,846 = 6.87, p = 0.001, gp
2 = 0.02; multivariate effects of MANOVA, Wilk’s
Lambda = 0.93, F8,1688 = 7.97, p\ 0.001, gp
2 = 0.04
1Pairwise comparisons applied to non-smokers group: depression symptoms, p = 0.015, anxiety symptoms,
p = 0.003
2Pairwise comparisons applied to quitters group: depression symptoms, p = 0.035, anxiety symptoms,
p = 0.045
3Pairwise comparisons applied to smokers group: depression symptoms, p = 0.117, anxiety symptoms,
p = 0.127
I1 versus 2, p = 0.130; 1 versus 3, p\ 0.001; 2 versus 3, p = 0.036
II1 versus 2, p = 0.814; 1 versus 3, p\ 0.001; 2 versus 3, p = 0.001
III1 versus 2, p = 0.190; 1 versus 3, p\ 0.001; 2 versus 3, p = 0.028
IV1 versus 2, p = 0.816; 1 versus 3, p\ 0.001; 2 versus 3, p = 0.003
***p\ 0.001
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The second step regression was statistically significant
(v10
2 = 29.63, p = 0.001). The model explained 13–17%
of the variance in continued tobacco consumption (Cox and
Snell R2 = 0.13, Nagelkerke R2 = 0.17) and correctly
classified 67.3% of cases. More anxiety symptoms at the
first trimester (OR = 1.03) increased the probability of
continued smoking during pregnancy.
The third step regression was statistically significant
(v10
2 = 38.64, p = 0.001). The model explained 17–22% of
the variance in continued tobacco consumption (Cox and
Snell R2 = 0.17, Nagelkerke R2 = 0.22) and correctly
classified 67.3% of cases. More depression symptoms at
the third trimester (OR = 1.14) were associated with con-
tinued smoking during pregnancy (see Table 3).
Discussion
Depression and anxiety symptoms trajectories from the first
to the third trimester of pregnancy were in the present study
similar to the ones found in the literature, that is a decrease
in anxiety and depression symptoms from the first to the
third trimester of pregnancy (e.g. Andersson et al. 2006;
Figueiredo and Conde 2011). Interestingly, depression and
anxiety symptoms changes from the first to the third tri-
mester of pregnancy are different in non-smokers versus
quitters versus continuous smokers during pregnancy, with
continuous smokers not exhibiting the normative decrease
in depression and anxiety symptoms across pregnancy, as
found in quitters and non-smokers. Moreover, anxiety
symptoms at the first trimester were associated with con-
tinued smoking during pregnancy. Additionally, continued
smoking during pregnancy was associated with more
depression symptoms at the third trimester. These results
clarify how anxiety and depression symptoms are related to
continued smoking during pregnancy.
Several socio-demographic, obstetric, and psychological
differences were found between continuous smokers,
quitters, and non-smokers. These data suggest that two-by-
two smoking status group comparisons (e.g. smokers vs.
non-smokers) performed in previous studies (e.g. Al-Sahab
et al. 2010; Orr et al. 2012) may underrepresent the results.
The group of women who did not smoke, formed by non-
smokers and quitters, is not an uniform group, and the
variables associated with not smoking during pregnancy
are not always the same as those associated with the ces-
sation of consumption. For example, regarding parity, the
group of non-smokers has the highest percentage of mul-
tiparous women (37.0%), while the group of quitters has
the highest percentage of primiparous women (79.7%).
Therefore, joining both groups could result that the dif-
ferences in function of parity were minimized or even
disappeared.
Regression analyses showed that to have a low level of
studies, to have a smoking partner, and to present higher
levels of anxiety symptoms at the first trimester of preg-
nancy and higher levels of depression symptoms at the
third trimester are associated with continuous consumption
during pregnancy. When only the first trimester was con-
sidered, results showed that higher levels of anxiety
symptoms increased the probability of continued smoking
during pregnancy. The greater importance of anxiety
symptoms at the first trimester of pregnancy may be related
to the fact that the early pregnancy period represents a time
of great risks for pregnancy (Mook-Kanamori et al. 2010).
Pregnant women not only have to adapt to their new situ-
ation, but also have to face concerns about the viability of
pregnancy and/or the health of the foetus. The relationship
between lower education and continuous tobacco con-
sumption could be explained by not being fully aware of
the harmful effects of tobacco use on the health of both the
pregnant women and the unborn child (Driezen et al.
2016). In addition, living with other smokers is also asso-
ciated with increased need to smoke due to a ‘‘contagion
effect’’ and mean a greater availability of tobacco at home
that is difficult for the women’s control of stimulus (Doz
et al. 2004). The relationship between higher levels of
Fig. 1 Differences on Spanish women’s depression (Edinburgh
Postnatal Depression Scale mean scores) and anxiety symptoms
(State Anxiety Scale of State-Trait Anxiety Inventory mean scores)
from the first to the third trimester of pregnancy, according to
smoking status in 2014. Significant changes are represented with a
continuous line
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anxiety symptoms at the first trimester and continuing
smoking have been found in the literature (e.g. Goedhart
et al. 2009) and could be explained by the presence of more
stress according to the identified risk factors present in
women who continued smoked during pregnancy (they
were less likely to be married or partnered and to receive a
higher monthly salary). Moreover, this relationship can
also be sustained by the belief that smoking helps to relax
and control negative emotions (Irwin et al. 2005), becom-
ing a coping strategy. However, our data do not support
this belief, since no decrease in the levels of anxiety and
depression across pregnancy was found in women who
continued smoking during pregnancy, contrarily to what
was observed in both non-smokers and quitters. Moreover,
when both the first and the third trimesters were consid-
ered, a significant association was found between contin-
uous tobacco consumption and depression symptoms at the
third trimester. Although smoking can be used as a tool to
cope with negative mood (Zhu and Valvo 2002), our results
suggested that continued smoking during pregnancy could
increase depression symptoms.
Regarding the differences on women’s depression and
anxiety symptoms from the first to the third trimester of
pregnancy according to smoking status, our data show that
Table 3 Depression and anxiety
symptoms as predictors of
continued tobacco consumption
(quitters vs. continuous
smokers) among Spanish
pregnant women
b Wald p OR 95% CI
Step 1 (enter method)
Marital status 0.05 0.02 0.90 1.05 0.51–2.16
No college degree 0.90 6.50 0.01* 2.46 1.23–4.95
Parity 0.66 3.73 0.05 1.93 0.99–3.76
Pregnancy-influenced work 0.07 0.03 0.86 0.94 0.47–1.88
Pregnancy desired 0.07 0.03 0.86 0.93 0.42–2.07
Breastfeeding intention 0.16 0.14 0.71 1.17 0.52–2.64
Previous psychopathology 0.55 1.93 0.17 0.58 0.27–1.25
Salary 0.54 1.99 0.16 1.72 0.81–3.64
Smoking partner 0.82 7.30 0.01* 2.27 1.25–4.10
Step 2 (stepwise method)
Marital status 0.19 0.25 0.62 1.21 0.57–2.55
No college degree 0.86 5.76 0.02* 2.37 1.17–4.78
Parity 0.58 2.71 0.10 1.78 0.90–3.53
Pregnancy-influenced work 0.10 0.07 0.79 1.10 0.54–2.26
Pregnancy desired 0.18 0.18 0.68 0.84 0.37–1.91
Breastfeeding intention 0.09 0.05 0.83 1.10 0.48–2.52
Previous psychopathology 0.48 1.41 0.24 0.62 0.28–1.37
Salary 0.54 1.88 0.17 1.71 0.80–3.67
Smoking partner 0.92 8.74 \ 0.01** 2.51 1.36–4.63
Anxiety symptoms at first trimester 0.03 6.02 0.01* 1.03 1.01–1.06
Step 3 (stepwise method)
Marital status 0.21 0.30 0.58 1.24 0.58–2.64
No college degree 0.83 5.04 0.03* 2.29 1.11–4.72
Parity 0.57 2.52 0.11 1.77 0.87–3.59
Pregnancy-influenced work 0.06 0.03 0.87 1.06 0.52–2.19
Pregnancy desired 0.17 0.15 0.70 0.85 0.37–1.93
Breastfeeding intention 0.17 0.15 0.70 1.18 0.50–2.77
Previous psychopathology 0.37 0.83 0.36 0.69 0.31–1.54
Salary 0.50 1.50 0.22 1.64 0.74–3.64
Smoking partner 0.91 8.09 \ 0.01** 2.48 1.33–4.63
Anxiety symptoms at first trimester 0.03 5.42 0.02* 1.03 1.01–1.06
Depression symptoms at third trimester 0.14 8.42 \ 0.01** 1.14 1.05–1.25
Data collection: Spain, 2013–2014
OR odds ratio, CI confidence interval
*p\ 0.05; **p\ 0.01
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quitting is associated with a reduction in depression and
anxiety symptoms, so there is an improvement in mental
health, as noted by Taylor et al. (2014). Thus, it can be
observed that the levels of depression and anxiety symp-
toms of women who spontaneously quit smoking at the first
trimester of pregnancy decrease to similar levels of women
who do not smoke, as non-significant differences were
found between both groups. Likewise, our data also seem
to corroborate that smoking could increase mental health
problems (Flensborg-Madsen et al. 2011; Minichino et al.
2013). Continuous smokers maintain the highest levels of
anxiety and depression symptoms throughout pregnancy,
as significant differences were found with the group of
non-smokers and quitters both at the first and at the third
trimester of pregnancy.
One variable that stands out and which contribute should
be better analysed in future studies on smoking during
pregnancy and the post-partum period is breastfeeding
intention and duration. In line with the literature, signifi-
cant differences between the smoking status groups were
found regarding breastfeeding intention, with smokers
having the lower intentionality to breastfeed. Previous
studies have related both depression symptoms and tobacco
consumption status to breastfeeding. Specifically, higher
levels of depression symptoms both during pregnancy
(Figueiredo et al. 2014; Ystrom 2012) and during the post-
partum (Ystrom 2012) were associated with breastfeeding
no-intention, no-initiation, or early cessation. Likewise,
continued smoking during pregnancy was related to
breastfeeding no-initiation or a shorter duration (Giglia
et al. 2007; Suzuki et al. 2010). A relationship between
quitting smoking in early pregnancy and the intention to
breastfeed was found in the present study and has also been
suggested in the literature. Women who intend to breast-
feed are less likely to smoke and more likely to sponta-
neously quit smoking during pregnancy (Haslam et al.
2003; Joseph et al. 2017). These data suggest the impor-
tance of promoting breastfeeding to improve smoking
cessation and reduce depression symptoms, as well as the
possible importance of improving smoking cessation and
reducing depression symptoms to promote breastfeeding.
Some limitations should be considered. Pre-pregnancy
psychological assessments were not conducted, which does
not allow to know how pregnancy affected the process of
tobacco quitting due to anxiety and depression symptoms.
In addition, depression and anxiety symptoms were asses-
sed through self-reported measures.
Despite these limitations, this study has several
strengths. Firstly, a large sample was used to study
simultaneously relevant factors that previous research has
found to be related to smoking during pregnancy. Sec-
ondly, this is a longitudinal study that assessed continued
consumption and continued abstinence over pregnancy and
performed comparisons between the three consumption
groups (non-smokers, quitters, and continuous smokers).
We consider that the variables associated with continuous
abstinence or consumption are the most important variables
to analyse because the objective should not be to achieve
abstinence at a certain time of pregnancy, but the mainte-
nance during all pregnancy. Moreover, the pregnant
women’s self-reports of smoking abstinence were bio-
chemically validated to control for social desirability bias.
This is particularly relevant during pregnancy when higher
social pressure for women not smoking is present (Mı´guez
and Pereira 2018).
In conclusion, this study showed how levels of depres-
sion and anxiety are influenced both by the time of preg-
nancy evaluated and by the smoking status, with
continuous smokers during pregnancy at risk of increasing
anxiety and depression symptoms. The main clinical
implications of our results concern the relevance of
screening for anxiety and depression early in pregnancy to
identify women at risk of smoking during the entire preg-
nancy. Also, this study reinforces the idea that future pre-
natal smoking cessation interventions must take into
account these variables.
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